Chronic Urticaria Is Independently Associated with Atherosclerotic Cardiovascular Disease: A National Cohort Study of the MarketScan Databases [0.03%]
慢性荨麻疹与动脉粥样硬化性心血管疾病独立相关：来自动脉粥样硬化性疾病市场扫描数据库的全国队列研究结果
Julian A Cortes,Yvonne Nong,Kimberly Smart et al.
Julian A Cortes et al.
48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients [0.03%]
莱比库单抗治疗特应性皮炎的48周真实世界结果：未经全身治疗与经全身治疗患者
Teppei Hagino,Akihiko Uchiyama,Hidehisa Saeki et al.
Teppei Hagino et al.
Background: An anti-interleukin (IL)‑13 antibody, lebrikizumab, has shown efficacy in the treatment of atopic dermatitis (AD). However, real‑world data on 1‑year transition of clinical and laboratory indices are limite...
Correction to: Past, Present, and Future of Sodium Hypochlorite in Dermatology: A Scoping Review [0.03%]
对“皮肤病学中的次氯酸钠的过去、现在和未来：系统综述”的勘误通知
Christy H Chang,Maura Devine,Deborah Woo et al.
Christy H Chang et al.
Published Erratum
American journal of clinical dermatology. 2026 Apr 18. DOI:10.1007/s40257-026-01024-3 2026
Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis Treatment [0.03%]
从患者的角度识别最相关的特应性皮炎治疗(eczema area and severity index阈值)
Lawrence F Eichenfield,Peter A Lio,Alan D Irvine et al.
Lawrence F Eichenfield et al.
Background: Atopic dermatitis (AD) is a chronic inflammatory disease significantly impacting patients' quality of life (QoL). While multiple outcome measures exist, a critical gap remains in establishing treatment goals t...
The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes? [0.03%]
GLP-1受体激动剂对头发的影响：益处还是不良后果？
S Morteza Seyed Jafari,Gemma Caro,Shari R Lipner et al.
S Morteza Seyed Jafari et al.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed the treatment of type II diabetes and obesity. Since their introduction, studies continue to reveal their beneficial effects in a range of other conditions. However, hair...
Acute and Chronic Cutaneous Graft-versus-Host Disease: Diagnosis, Treatment, and Emerging Directions [0.03%]
急性和慢性皮肤移植物抗宿主病的诊断、治疗及未来方向
Connie R Shi,Mihir K Patil,Grant J Riew et al.
Connie R Shi et al.
Cutaneous graft-versus-host disease (GVHD) is a frequent manifestation after allogeneic hematopoietic stem cell transplantation. This review synthesizes classification, pathophysiology, risk factors, and diagnostic frameworks for acute and ...
Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances [0.03%]
头皮分隔性皮炎的诊疗进展及最新研究
Luca Valtellini,Gabriele Perego,Italo Francesco Aromolo et al.
Luca Valtellini et al.
Dissecting cellulitis of the scalp is a rare, primary neutrophilic cicatricial alopecia that manifests with painful nodules, abscesses, and interconnected sinus tracts. It predominantly affects young adult men and frequently coexists with o...
Emerging Therapeutic Strategies in Cutaneous T-Cell Lymphoma: A Comprehensive Review of Clinical Trials [0.03%]
皮病T细胞淋巴瘤治疗策略的临床研究综合述评
Yoni Sacknovitz,Rachel Ma,Christina M Bear et al.
Yoni Sacknovitz et al.
Background: Cutaneous T-cell lymphomas (CTCL), including mycosis fungoides (MF) and Sézary syndrome (SS), are rare non-Hodgkin lymphomas characterized by skin-homing malignant T cells. While early-stage disease carries f...
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies [0.03%]
长期评价利特西替尼治疗斑秃成人和青少年患者的疗效和安全性：ALLEGRO II期b/III期和ALLEGRO-LT III期临床研究的3年结果
Maryanne Senna,Jennifer Soung,Ignasi Figueras et al.
Maryanne Senna et al.
Background/objective: Ritlecitinib, an oral JAK3/TEC family kinase inhibitor, demonstrated efficacy over 48 weeks in patients aged ≥ 12 years with alopecia areata (AA) in the ALLEGRO phase 2b/3 study and initial extensio...
Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need! [0.03%]
肿瘤幸存者的纠正性皮肤修复治疗：一个亟待解决的迫切需求！
Luca Rapparini,Timila Assia Touhouche,Davide Fattore et al.
Luca Rapparini et al.
The increasing efficacy of oncological therapies has led to a rapidly growing population of cancer survivors, shifting clinical attention from acute treatment-related toxicities to long-term and late sequelae. Among these, dermatological se...